Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.450
-0.090 (-2.54%)
At close: Aug 19, 2025, 4:00 PM
3.430
-0.020 (-0.58%)
After-hours: Aug 19, 2025, 4:04 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $128.82 million as of August 19, 2025. Its market cap has increased by 91.33% in one year.
Market Cap
128.82M
Enterprise Value
101.81M
1-Year Change
91.33%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $128.82M, a decrease of -9.08%. That is a compound annual growth rate of -3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 132.18M | 64.23% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.52B |
| Johnson & Johnson | 425.41B |
| AbbVie | 365.13B |
| UnitedHealth Group | 275.33B |
| AstraZeneca | 243.89B |
| Novartis AG | 239.15B |
| Abbott Laboratories | 229.31B |
| Novo Nordisk | 227.24B |